Skip to main content

Table 1 Demographic and clinical characteristics of the participants

From: Vaccination status, incidence of adverse events, and awareness of COVID-19 vaccine among outpatients undergoing chemotherapy

  

Number

%

Sex

Male

16

26.7

Female

44

73.3

Age (years)

< 40

3

5.0

40–49

15

25.0

50–59

21

35.0

60–69

13

21.7

70–79

8

13.3

≥ 80

0

0.0

History

Allergy

9

15.0

Experience of feeling unwell after receiving some vaccine

5

8.3

Vaccination

status

Never

2

3.3

1st dose

58

96.7

2nd dose

58

96.7

3rd dose

47

78.3

4th dose

21

35.0

Cancer

stage

Stage 0

0

0.0

Stage I

9

15.0

Stage II

13

21.7

Stage III

13

21.7

Stage IV

13

21.7

Unknown

12

20.0

Duration

of cancer

treatment

< 1 years

44

73.3

1–5 years

9

15.0

6–10 years

5

8.3

≥ 11 years

2

3.3

History of COVID-19

Have a history of COVID-19 without the vaccination

0

0.0

Have a history of COVID-19 before vaccination

2

3.3

Have a history of COVID-19 after vaccination

12

20.0

Have a history of COVID-19 both before and after vaccination

1

1.7

No history of COVID-19

45

75.0

  1. COVID-19, coronavirus disease